Aptose Biosciences to Present at Canaccord Genuity 35th Annual Growth Conference Aug 10, 2015 8:00am EDT
Aptose Biosciences Reports Results for the Second Quarter Ended June 30, 2015 Aug 04, 2015 4:07pm EDT
Aptose Biosciences to Host Second Quarter Ended June 30, 2015 Financial Results Conference Call and Webcast Jul 30, 2015 8:00am EDT
Aptose Biosciences to Present at the 10th Annual JMP Securities Life Sciences Conference Jun 22, 2015 8:00am EDT
Aptose Biosciences announces results of annual and special meeting of shareholders Jun 10, 2015 5:00pm EDT
Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia Jun 02, 2015 2:00pm EDT
Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 May 05, 2015 4:15pm EDT
Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory Board Mar 23, 2015 8:30am EDT
Aptose Biosciences to Present at the 12th Annual BIO Asia International Conference Mar 23, 2015 8:00am EDT
